Neulasta
Active Ingredient(s): PegfilgrastimFDA Approved: * January 31, 2002
Pharm Company: * AMGEN
Category: Cancer
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.[5] It serves to stimulate the production of white blood cells (neutrophils).[5][7] Pegfilgrastim was developed by Amgen.[8] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemo... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.2 Discussions
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
Neulasta Side Effects
What side effects have others encountered while taking Neulasta? ## I don't have any personal experience with this m...
1 REPLY